Deutsche Bank’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-51
Closed -$8K 5660
2015
Q1
$8K Buy
+51
New +$7.49K ﹤0.01% 4840

Other funds holding SLXP

Deutsche Bank's SLXP Position: Q2 2015 in Review

Deutsche Bank sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 68,753 shares — an estimated $11.9M sold.

Deutsche Bank first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $43.1M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Deutsche Bank reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Deutsche Bank sold 68,753 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $11.9M.
  • Deutsche Bank first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Deutsche Bank's SALIX PHARMACEUTICALS LTD DEL position peaked at $43.1M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Deutsche Bank's 13F filing for Q2 2015, filed 12 Aug 2015.